Rapid blood-based assay for traumatic brain injury diagnosis using dual biomarkers (GFAP and UCH-L1) with magnetic particle immunoassay technology. Delivers results in 15-50 minutes on a fully automated platform, enabling quick and accurate detection of brain concussions and traumatic brain injuries...
Manufactured by
South Korea
VEUS, the abbreviation of Versatile, Easy, and User-friendly System, is a diagnostic system: Versatile – almost all in vitro diagnostic items are applicable; Easy – the system entirely automated enabling easy testing with no pretreatment required; User-friendly – anybody can use the system easily. Furthermore, it delivers rapid and accurate results for efficient clinical decision-making.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
IBL-America
United States · 2 relevant products
SHENZHEN ANQUN BIOTECH CO.,LTD.
China · 1 relevant product
Fujirebio Europe
Belgium · 2 relevant products
Rapid Technology LLC
Russia · 3 relevant products
INTA S.r.l.
Italy · 2 relevant products
Abbott
United States · 2 relevant products
ABCDx
Spain · 4 relevant products
Assure Tech. (Hangzhou) Co., Ltd.
China · 1 relevant product
Lansion Biotechnology Co., Ltd.
China · 3 relevant products
Shi Ji Yi kang (Tianjin) Medical Technology Development Co., Ltd.
China · 2 relevant products
57 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 91 closest product alternatives
IBL-America · United States
Enzyme immunoassay for semi-quantitative determination of soluble terminal complement complex (sTCC) in human EDTA plasma. Measures complement system activation for research purposes.
SHENZHEN ANQUN BIOTECH CO.,LTD. · China
Enzyme-linked immunoassay kit for quantitative detection of phosphorylated tau-181 (p-tau181) in human serum or plasma. Designed for early diagnosis and monitoring of neurodegenerative diseases, particularly Alzheimer's disease and dementia. Provides rapid, reliable biomarker measurement for clinical and research applications.
Fujirebio Europe · Belgium
Automated blood-based assay for total tau protein measurement. Provides quantitative assessment of neurodegeneration in neurodegenerative disease evaluation.
Fujirebio Europe · Belgium
A fully automated assay measuring soluble TREM2 protein for research use in neurological disease investigation. The assay supports understanding of neuroinflammation in neurodegenerative diseases.
Rapid Technology LLC · Russia
Rapid diagnostic test for assessment of traumatic brain injury using key biomarkers.
INTA S.r.l. · Italy
A specialized diagnostic test detecting up to six traumatic brain injury biomarkers from a single drop of blood using the NanoAnalyzer platform. Results are displayed within minutes via AI-powered analysis, enabling rapid clinical decision-making in emergency settings.
Abbott · United States
Mild traumatic brain injury biomarker diagnostic test designed to improve emergency department care and clinical decision-making through rapid, accurate diagnosis.
ABCDx · Spain
A point-of-care diagnostic test that detects mild traumatic brain injury using a drop of blood from a finger prick. TBICheck identifies a combination of biomarkers to detect brain lesions and can rapidly discharge patients with suspected brain injury within 15 minutes, avoiding the need for CT-scan in approximately half of traumatic brain injury patients with no brain injury.
Assure Tech. (Hangzhou) Co., Ltd. · China
Rapid immunochromatographic assay for detection of cardiac biomarkers including troponin and myoglobin. Enables quick assessment of myocardial injury in emergency and clinical settings.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for neurological injury assessment. Supports rapid detection of brain injury biomarkers.
Abbott · United States
Biomarker diagnostic test for mild traumatic brain injury assessment designed to improve emergency department clinical decision-making and patient care outcomes.
Rapid Technology LLC · Russia
Point-of-care diagnostic test for detecting ischemic stroke and traumatic brain injury based on biomarkers.
79 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products